Posted in | News | Laser

Key Milestone in Boeing's Advanced Tactical Laser Program

The Boeing Company has fired a high-energy chemical laser aboard a C-130H aircraft in ground tests for the first time, achieving a key milestone for the Advanced Tactical Laser (ATL) Advanced Concept Technology Demonstration program.

The successful laser firing occurred May 13 at Kirtland Air Force Base, N.M.

"First firing of the high-energy laser aboard the ATL aircraft shows that the program continues to make good progress toward giving the warfighter an ultra-precision engagement capability that will dramatically reduce collateral damage," said Scott Fancher, vice president and general manager of Boeing Missile Defense Systems.

After conducting a series of additional laser tests on the ground and in the air, the program will fire the chemical laser in-flight at mission-representative ground targets. The test team will fire the laser through a rotating turret that extends through the aircraft's belly.

"Later this year, we will fire the laser in-flight at ground targets, demonstrating the military utility of this transformational directed energy weapon," Fancher said.

Last year, the high-energy laser concluded laboratory testing at Kirtland, demonstrating reliable operations in more than 50 firings.

ATL, which Boeing is developing for the U.S. Department of Defense, will destroy, damage or disable targets with little to no collateral damage, supporting missions on the battlefield and in urban operations. Boeing's ATL industry team includes L-3 Communications/Brashear, which made the laser turret, and HYTEC Inc., which made various structural elements of the weapon system.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.